Zai Lab Limited (ZLAB)

Trade ZLAB now with
1/12/2022 7:37:32 AM Zai Lab Announces First Patient Treated In Greater China In PANOVA-3 Phase 3 Pivotal Trial
12/15/2021 10:38:44 AM Zai Lab Stock Down 18%
11/30/2021 7:34:13 AM Zai Lab Announces Positive Topline Results From Phase 3 PRIME Study Of ZEJULA
11/22/2021 7:33:31 AM Zai Lab Appoints Richard Gaynor To Board
11/11/2021 7:38:16 AM Zai Lab Doses First Patient In Greater China In Global Registrational Clinical Trial Of Efgartigimod
11/9/2021 8:11:16 AM Blueprint Medicines, Zai Lab Unveil Collaboration And License Deal For BLU-945 And BLU-701 In Greater China
11/9/2021 7:43:37 AM Karuna And Zai Lab Collaborate For Development, Manufacturing, And Commercialization Of KarXT In Greater China
10/18/2021 7:43:44 AM Zai Lab Appoints Scott Morrison To Board
10/4/2021 7:50:06 AM Novocure, Zai Lab Announce Last Patient Enrolled In Phase 2 Pilot Trial Of Tumor Treating Fields Plus Chemotherapy
9/14/2021 7:39:01 AM Zai Lab Announces Breakthrough Therapy Designation Granted For Bemarituzumab In China
8/25/2021 8:36:50 AM Zhongchao Expands Patient Management Business To Ovarian Cancer Market
8/4/2021 7:38:11 AM Schrdinger And Zai Lab Announce Global R&D Collaboration In Oncology
6/1/2021 7:31:43 AM Mirati Therapeutics And Zai Lab Collaborate To Develop Adagrasib In Greater China
5/28/2021 7:39:28 AM Zai Lab Says Dosed First Patient In China In Phase 2 Portion Of TRIDENT-1 Study Of Repotrectinib
4/20/2021 9:54:08 PM Zai Lab Prices Underwritten Public Offering Of 4.78 Mln ADSs At US$150.00/ADS